MYH7 and cancer: In this study, the expression of MYH7 was up-regulated in the liver tissues of mice treated with ustilaginoidin D, indicating that mice treated with ustilaginoidin D have a risk of heart disease, and the down-regulation of ITGAV may be closely related to cancer markers.